AnalysisNews

KALA today

$0.17+$0.00 (+0.00%)close Nov 11, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bearish

1 hourLeaning Bearish

15 minStrong Bearish

5 minStrong Bearish

Daily trend turns up above $0.61

Key levels

Resistance$0.61

Resistance$0.49

Support$0.11

Latest news & SEC filings

SEC FilingKALA BIO, Inc. filed a report on a major company event (Form 8-K)

All KALA news →

About KALA BIO

KALA BIO is a biopharmaceutical company that formerly developed treatments for rare eye conditions, including a stem cell-based candidate for persistent corneal epithelial defects. After halting that program, it now seeks to monetize its remaining biologics intellectual property and is exploring an on-premises artificial intelligence platform for life sciences research. The intended AI offering would serve mid-sized biotech firms, clinical research providers, and drugmakers, with deployment inside the customer's own systems.

Based on the company's 10-K filed Apr 15, 2026.

Nasdaq · Healthcare

KALA BIO, Inc. (KALA)

$0.17+0.00 (+0.00%)
REDUCEGrade: DRisk: HIGH
1D5D1M1Y5YMaxSign up for all timeframes
0.210.260.310.370.17Oct 9Oct 19Oct 27Nov 4
High0.17
Low0.17
Open0.17
Volume82K
Avg Vol371K
VWAP0.17
30d High0.42
30d Low0.15
30d Chg-59.23%

What Is the Price Target for KALA?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.17Upside: +0.0%Confidence: 20%Method: No Coverage

Is KALA a Buy or Sell Right Now?

27
Investability Score
REDUCE12-18 months

Thesis

  • •Revenue growing -65.4% YoY with UNKNOWN trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KALA.

Start Free Trial →

Is KALA Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

PEG

Fair Value

$-0.07

10

Moat Score

NONE

2/9

Piotroski Score

-114.9

Altman Z-Score

What Is Smart Money Doing with KALA?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

KALA Growth Story

Revenue YoY

-65.4%

3yr Revenue CAGR

N/A%

EPS Growth YoY

67.39%

FCF Growth YoY

N/A%

Revenue Trend

UNKNOWN

Dark Pool Trades for KALA

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for KALA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
13:00:20$0.155,500$$820SELL
13:00:18$0.172,262$$387SELL
23:03:07$0.1715,820$$3KSELL
21:47:53$0.173,000$$525BUY
19:23:03$0.172,000$$344BUY

5 dark pool trades shown · $$5K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for KALA BIO, Inc. (KALA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

KALA — frequently asked questions

What is KALA stock price today?

KALA BIO, Inc. (KALA) is at $0.17, up 0.00% (+$0.00) at the Nov 11, 2026 close.

Why is KALA stock moving today?

Latest KALA news — Nov 9, 2026: KALA BIO, Inc. filed a report on a major company event (Form 8-K)

Did KALA beat earnings?

KALA last reported on Aug 19, 2026: EPS -$21.32 vs -$6.00 expected — a miss of 255.3%.

What is KALA's P/E ratio?

KALA trades at a P/E of 0.0 vs a Healthcare average of 17.7.

Does KALA pay a dividend?

KALA does not currently pay a dividend.

What are KALA support and resistance levels?

Support: $0.11. Resistance: $0.49, $0.61, $0.70.

What are insiders doing with KALA?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on KALA?

Nov 9, 2026: KALA BIO, Inc. filed a report on a major company event (Form 8-K)